After an amazing run, is CrowdStrike stock setting up for another big move as it leads the cybersecurity group?
Here are the top picks for betting on the Men's NCAA Tournament's Sweet 16 games on Thursday.
The U.S. Food and Drug Administration has extended its review of Applied Therapeutics' experimental drug to treat galactosemia, a rare genetic metabolic disease, the company said on Thursday. There are currently no approved treatments for the disease in the United States, which has about 3,000 Galactosemia patients. The FDA delayed its decision on the drug, govorestat, saying it requires additional time to review supplemental analyses submitted by the company.